Trans epithelial versus epithelium-off corneal cross-linking for the treatment
Click here to load reader
-
Upload
abada-fida -
Category
Health & Medicine
-
view
406 -
download
1
Transcript of Trans epithelial versus epithelium-off corneal cross-linking for the treatment
![Page 1: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/1.jpg)
Trans-epithelial Versus Epithelium-off Corneal
Cross-linking for the Treatment of Progressive
Keratoconus: A Randomized Controlled Trial
NIENKE SOETERS, ROBERT P.L. WISSE, DANIEL A. GODEFROOIJ
AMERICAN JOURNAL OF OPHTHALMOLOGY, MAY 2015
![Page 2: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/2.jpg)
PURPOSE
To compare the clinical effects and safety of trans-epithelial corneal cross-
linking (CXL) to epithelium-off (epi-off) CXL in progressive keratoconus.
![Page 3: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/3.jpg)
DESIGN: Randomized clinical trial (noninferiority).
METHODS: Patients received either trans-epithelial CXL with Ricrolin TE (n [ 35) or epi-off CXL with isotonic riboflavin (n [ 26)
in 1 academic treatment center, using a simple unrestricted
randomization procedure. The main outcome measure was
clinical stabilization of keratoconus after 1 year, defined as a
maximal keratometry (Kmax) increase <1 diopter (D).
![Page 4: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/4.jpg)
SURGICAL TECHNIQUE:
In the trans-epithelial CXL group
Local anesthetic eye drops (oxybuprocaine 0.4% and tetracaine 1%)
were applied 3 times during 5 minutes, and Ricrolin TE solution (consisting
of riboflavin 0.1% eye drops with Dextran T500 15 mg and EDTA; SOOFT
Italia) were instilled every 2 minutes for 15 minutes. Next, an eyelid
speculum was placed and a silicone ring was positioned between the eyelids; the ring was filled with Ricrolin TE and used to retain a Ricrolin
‘‘pool’’ on the cornea. After 15 minutes, the silicone ring was removed,
the cornea was rinsed with balanced salt solution, and pachymetry was
performed. UVA irradiation was performed during 30 minutes, while
Ricrolin TE solution was reapplied to the cornea every 5 minutes.
![Page 5: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/5.jpg)
Epi-off CXL technique
was performed following the Dresden protocol, adjusted with the
avoidance of the eyelid speculum during riboflavin instillation. Epithelial
removal (9-mm) was performed using a blunt knife. After pachymetry
measurements, isotonic riboflavin 0.1% solution with 20% Dextran (Medio
Cross) was applied every 3 minutes for 30 minutes, with no eye lid
speculum in place
![Page 6: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/6.jpg)
RESULTS
Average Kmax was stable at all visits in the transepithelial group, while after epi-off CXL a significant flattening of 1.2–1.5 D was demonstrated from the 3-month follow-up onwards. The trend over time in Kmax flattening was significantly different between the groups.
There was significant different trend in corrected distance visual acuity (CDVA), with a more favorable outcome in thetransepithelial group.
In the transepithelial group no complications were observed while in epi-off group, 4 eyes (15%) developed complications owing to healing problems (sterile infiltrate, herpes keratitis, central haze, and stromal scar).
![Page 7: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/7.jpg)
![Page 8: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/8.jpg)
![Page 9: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/9.jpg)
![Page 10: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/10.jpg)
DISCUSSION
This trial showed that transepithelial cross-linking with EDTA riboflavin* was
less effective to halt keratoconus progression after 1 year compared to
epithelium-off cross-linking.
![Page 11: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/11.jpg)
indicators for a CXL effect
General indicators (with stabilization being the main purpose) are a
1. visible demarcation line,
2. a flattened keratometry, and
3. reduced pachymetry.
![Page 12: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/12.jpg)
No demarcation line was found in the transepithelial CXL group and the
average central keratometry, maximal keratometry, and pachymetry were
unchanged after treatment.
The average Kmax flattening after 1 year in the epi-off group in this study
was more pronounced (-1.5 D).
![Page 13: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/13.jpg)
![Page 14: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/14.jpg)
CONCLUSION
This study showed that although transepithelial CXL was a safe procedure
without epithelial healing problems, 23% of cases showed a continued
keratoconus progression after 1 year
![Page 15: Trans epithelial versus epithelium-off corneal cross-linking for the treatment](https://reader037.fdocuments.in/reader037/viewer/2022100807/588219221a28ab3f4c8b6017/html5/thumbnails/15.jpg)